Erratum to Genotypic and antimicrobial susceptibility of carbapenem-resistant Acinetobacter baumannii: Analysis of ISAba elements and blaOXA-23-like genes including a new variant [Front. Microbiol., 6 (2015):1249 DOI:10.3389/fmicb.2015.01249];Genotypic and Antimicrobial Susceptibility of Carbapenem-resistant Acinetobacter baumannii: Analysis of is Aba Elements and blaOXA-23-like Genes Including a New Variant

Frontiers in Microbiology

Volumn 6, Issue NOV, 2015, Pages

  Bahador, Abbas ^a   Raoofian, Reza ^b,c   Pourakbari, Babak ^a   Taheri, Mohammad ^d   Hashemizadeh, Zahra ^d   Hashemi, Farhad B ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b LEGAL MEDICINE RESEARCH CENTER   (Iran)

^c Islamic Azad University   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; blaOXA 23 like gene; Carbapenemase; Novel mutations; BlaOXA 23 like gene

Indexed keywords

BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; IMIPENEM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AMPLICON; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CARBAPENEMASE GENE; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; ENZYME ACTIVITY; GENE EXPRESSION; GENE INSERTION SEQUENCE; GENE MUTATION; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS;

EID: 84949813048     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01430     Document Type: Erratum

References (38)

1. Abbott, I., Cerqueira, G. M., Bhuiyan, S., and Peleg, A. Y. (2013). Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev. Anti Infect. Ther. 11, 395-409. doi: 10.1586/eri.13.21
2. Alfandari, S., Gois, J., Delannoy, P. Y., Georges, H., Boussekey, N., Chiche, A., et al. (2014). Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. Med. Mal. Infect. 44, 229-231. doi: 10.1016/j.medmal.2014.03.005
3. Bahador, A., Bazargani, A., Taheri, M., Hashemizadeh, Z., Khaledi, A., Rostami, H., et al. (2013a). Clonal lineages and virulence factors among Acinetobacter baumannii isolated from Southwest of Iran. J. Pure Appl Microbiol. 7, 1559-1566.
4. Bahador, A., Taheri, M., Pourakbari, B., Hashemizadeh, Z., Rostami, H., and Mansoori, N. (2013b). Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb. Drug. Resist. 19, 397-406. doi: 10.1089/mdr.2012.0233
5. Bahador, A., Raoofian, R., Taheri, M., Pourakbari, B., Hashemizadeh, Z., and Hashemi, F. B. (2014). Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile. Microb. Drug Resist. 20, 632-640. doi: 10.1089/mdr.2013.0146
6. Clark, R. B. (1996). Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein. J. Antimicrob. Chemother. 38, 245-251.
7. Clinical Laboratory Standards Institute (CLSI) (2015). Performance Standards for Antimicrobial Susceptibility Testing: Twenty fourth Informational Supplement M100-S25. Wayne, PA: CLSI.
8. Couture, F., Lachapelle, J., and Levesque, R. C. (1992). Phylogeny of LCR-1 and OXA-5 with class A and class D β-lactamases. Mol. Microbiol. 6, 1693-1705. doi: 10.1111/j.1365-2958.1992.tb00894.x
9. Daoust, D. R., Onishi, H. R., Wallick, H., Hendlin, D., and Stapley, E. O. (1973). Cephamycins, a new family of beta-lactam antibiotics: antibacterial activity and resistance to β-lactamase degradation. Antimicrob. Agents Chemother. 3, 254-261. doi: 10.1128/AAC.3.2.254
10. D'Arezzo, S., Principe, L., Capone, A., Petrosillo, N., Petrucca, A., and Visca, P. (2011). Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J. Antimicrob. Chemother. 66, 54-61. doi: 10.1093/jac/dkq407
11. Evans, B. A., and Amyes, S. G. (2014). OXA β-lactamases. Clin. Microbiol. Rev. 27, 241-263. doi: 10.1128/CMR.00117-13
12. Garnacho-Montero, J., Amaya-Villar, R., Ferrándiz-Millón, C., Díaz-Martín, A., López-Sánchez, J. M., Gutiérrez-Pizarraya, A., et al. (2015). Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia. Expert. Rev. Anti. Infect. Ther. 13, 769-777. doi: 10.1586/14787210.2015.1032254
13. Higgins, P. G., Dammhayn, C., Hackel, M., and Seifert, H. (2010a). Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65, 233-238. doi: 10.1093/jac/dkp428
14. Higgins, P. G., Lehmann, M., Wisplinghoff, H., and Seifert, H. (2010b). gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J. Clin. Microbiol. 48, 4592-4594. doi: 10.1128/JCM.01765-10
15. Jones, L. S., Toleman, M. A., Weeks, J. L., Howe, R. A., Walsh, T. R., and Kumarasamy, K. K. (2014). Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India. Antimicrob Agents Chemother. 58, 4211-4213. doi: 10.1128/AAC.02500-14
16. Kempf, M., and Rolain, J. M. (2011). Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int. J. Antimicrob. Agents 39, 105-114. doi: 10.1016/j.ijantimicag.2011.10.004
17. Lee, H. Y., Chang, R. C., Su, L. H., Liu, S. Y., Wu, S. R., Chuang, C. H., et al. (2012). Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Int. J. Antimicrob. Agents 40, 163-167. doi: 10.1016/j.ijantimicag.2012.04.018
18. Lin, M. F., Kuo, H. Y., Yeh, H. W., Yang, C. M., Sung, C. H., Tu, C. C., et al. (2011). Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan. J. Microbiol. Immunol. Infect. 44, 39-44. doi: 10.1016/j.jmii.2011.01.008
19. Lu, P. L., Doumith, M., Livermore, D. M., Chen, T. P., and Woodford, N. (2009). Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J. Antimicrob. Chemother. 63, 641-647. doi: 10.1093/jac/dkn553
20. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., et al. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268-281. doi: 10.1111/j.1469-0691.2011.03570.x
21. Minami, S., Inoue, M., and Mitsuhashi, S. (1980). Purification and properties of cephalosporinase in Escherichia coli. Antimicrob. Agents Chemother. 18, 77-80. doi: 10.1128/AAC.18.1.77
22. Moradi, J., Hashemi, F. B., and Bahador, A. (2015). Antibiotic Resistance of Acinetobacter baumannii in Iran: a systemic review of the published literature. Osong. Public. Health. Res. Perspect. 6, 79-86. doi: 10.1016/j.phrp.2014.12.006
23. Mugnier, P. D., Poirel, L., Naas, T., and Nordmann, P. (2010). Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis.16, 35-40. doi: 10.3201/eid1601.090852
24. Onishi, H. R., Daoust, D. R., Zimmerman, S. B., Hendlin, D., and Stapley, E. O. (1974). Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to β-lactamase inactivation. Antimicrob. Agents. Chemother. 5, 38-48. doi: 10.1128/AAC.5.1.38
25. Peymani, A., Higgins, P. G., Nahaei, M. R., Farajnia, S., and Seifert, H. (2012). Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran. Int. J. Antimicrob. Agents 39, 526-528. doi: 10.1016/j.ijantimicag.2012.02.014
26. Potron, A., Munoz-Price, L. S., Nordmann, P., Cleary, T., and Poirel, L. (2011). Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti. Antimicrob. Agents Chemother. 55, 5946-5948. doi: 10.1128/AAC.05124-11
27. Potron, A., Poirel, L., and Nordmann, P. (2015). Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int. J. Antimicrob. Agents 45, 568-585. doi: 10.1016/j.ijantimicag.2015.03.001
28. Safari, M., Saidijam, M., Bahador, A., Jafari, R., and Alikhani, M. Y. (2013). High prevalence of multidrug resistance and metallo-β-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J. Res. Health Sci. 17, 162-167.
29. Saino, Y., Kobayashi, F., Inoue, M., and Mitsuhashi, S. (1982). Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrob. Agents Chemother. 22, 564-570. doi: 10.1128/AAC.22.4.564
30. Sartor, A. L., Raza, M. W., Abbasi, S. A., Day, K. M., Perry, J. D., Paterson, D. L., et al. (2014). Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan. Antimicrob. Agents Chemother. 58, 5589-5593. doi: 10.1128/AAC.02425-14
31. Sawai, T., Takahashi, I., and Yamagishi, S. (1978). Iodometric assay method for β-lactamase with various β-lactam antibiotics as substrates. Antimicrob. Agents Chemother. 13, 910-913. doi: 10.1128/AAC.13.6.910
32. Shahcheraghi, F., Abbasalipour, M., Feizabadi, M., Ebrahimipour, G., and Akbari, N. (2011). Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran. J. Microbiol. 3, 68-74.
33. Siroy, A., Molle, V., Lemaître-Guillier, C., Vallenet, D., Pestel-Caron, M., Cozzone, A. J., et al. (2005). Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. Antimicrob Agents Chemother. 49, 4876-4883. doi: 10.1128/AAC.49.12.4876-4883.2005
34. Sung, J. Y., Kwon, K. C., Cho, H. H., and Koo, S. H. (2011). Antimicrobial resistance determinants in imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii complex isolated in Daejeon, Korea. Korean. J. Lab. Med. 31, 265-270. doi: 10.3343/kjlm.2011.31.4.265
35. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2015). Breakpoint Tables for Interpretation of MICs and Zone Diameters Version 5.0. Available online at: http://www.eucast.org/clinical_breakpoints [Accessed January 01, 2015].
36. Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., et al. (2006). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS. Microbiol. Lett. 258, 72-77. doi: 10.1111/j.1574-6968.2006.00195.x
37. Vos, P., Hogers, R., Bleeker, M., Reijans, M., van de Lee, T., Hornes, M., et al. (1995). AFLP: a new technique for DNA fingerprinting. Nucleic. Acids. Res. 23, 4407-4414. doi: 10.1093/nar/23.21.4407
38. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., et al. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27, 351-353. doi: 10.1016/j.ijantimicag.2006.01.004